IL6 and Alzheimer disease: Sema6D has been demonstrated to promote the phagocytic uptake of oligomeric Aβ and the release of inflammatory cytokines like IL-1β, IL-6, TNF-α, and IL-8, regulating the function of microglial cells to increase the risk of AD (Finan et al., 2022).